Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology and programs exclusively in-licensed from Singapore-based Hummingbird Bioscience
TECNO Partners with Koç University to Advance Mobile Imaging Aesthetics in Türkiye
BARCELONA,Spain and ISTANBUL,March 4,2025-- TECNO,an AI-driven technology brand,is teaming up with Koç University in Türkiye,a leading research university located at the intersection of E
Create the AI Future: TECNO Unveils Next-Gen AI Ecosystem at MWC Barcelona 2025
TECNO will showcase its cutting-edge AI ecosystem,delivering practical AI solutions tailored for emerging markets. Highlights include the debut of the CAMON 40 imaging flagship smartphone,next-genera
Is foreign capital really withdrawing from China?
BEIJING,March 4,2025--A report from People\'s Daily: Lately,there has been much talk about foreign investors withdrawing from China on a large scale. Official data show that in 2024,foreign direct inv
-Earnings Call Scheduled for 8:30p.m. ET on March 17,2025- SHANGHAI,March 4,2025-- FinVolution Group ("FinVolution",or the "Company") (NYSE: FINV),a leading fintech platform,today
DXC and ServiceNow to Drive AI-powered Innovation for the Insurance Industry
ServiceNow and DXC expand their strategic partnership to combine DXC\'s industry-leading software and expertise with ServiceNow\'s AI-enabled platform
TAMPA,Fla.,March 4,2025--The United Soccer League (USL) and MAMMOTION,the company behind the LUBA 2 AWD series robotic lawn mowers,are joining forces to support the growth of soccer across the U.S. an
- XPOVIO® is the first and only approved XPO1 inhibitor in Indonesia. - From the second half of 2024 to now,XPOVIO®was successively approved in Thailand,Malaysia and Indonesia,significantly e
NYSE CONTENT ADVISORY: PRE-MARKET UPDATE + RARE DISEASE DAY AWARENESS
NEW YORK,Feb. 28,2025-- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Dr.Kinnari Patel,President,Head of R&D + COO at Rocket
Lanvin Group Prioritizes Creative Renewal and Operational Agility Amid Evolving Luxury Landscape
Revenue of €328 million in FY2024,a 23% decrease over FY2023,reflecting a transitional year marked by creative evolution and strategic realignment amid marketheadwinds